Displacement of striatal 5-hydroxytryptamine by dopamine released from endogenous stores
- 1 January 1985
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 37 (1) , 58-60
- https://doi.org/10.1111/j.2042-7158.1985.tb04932.x
Abstract
Combined treatment with amfonelic acid and neuroleptics caused a considerable loss of striatal, but not cortical 5-hydroxytryptamine (5-HT) in rats. This could be prevented by pretreatment with the specific 5-HT uptake inhibitor, citalopram. The results are best explained by the assumption that the combined treatment with amfonelic acid and neuroleptic had massively released dopamine into the synaptic cleft, and a part of this had been taken up into the 5-HT neurons by the 5-HT uptake mechanism and displaced the indoleamine.Keywords
This publication has 6 references indexed in Scilit:
- Reversibility of the interaction of CGP 11305 A with MAO A in vivoEuropean Journal of Pharmacology, 1983
- Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activityProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- Comparative effects of classical and atypical antipsychotic drugs in combination with a non-amphetamine stimulant on rat brain dopamine metabolismJournal of Pharmacy and Pharmacology, 1981
- THE DOPAMINE NEURONAL STORAGE SYSTEM AND NON-AMPHETAMINE PSYCHOTOGENIC STIMULANTS: A MODEL FOR PSYCHOSISPublished by Elsevier ,1979
- Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuronJournal of Pharmacy and Pharmacology, 1976
- Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphineJournal of Pharmacy and Pharmacology, 1976